TEVA PHARMACEUTICALS USA, INC.
Sign in to add to a watchlist →
lobbying_client · US · canonical: teva pharmaceuticals usa · 1 alias · 5 outbound · 3 inbound
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-18 · lobbied by Megan Sussman Herber · lda_lobbyist_client
- 2026-05-18 · lobbied by Elliot Vice · lda_lobbyist_client
- 2026-01-01 · lobbied on Preserve Access to Affordable Generics and Biosimilars Act (s 1096) · lobbying_bill_mention
- 2026-01-01 · lobbied on Stop STALLING Act (s 1095) · lobbying_bill_mention
- 2026-01-01 · lobbied on Interagency Patent Coordination and Improvement Act of 2025 (s 1097) · lobbying_bill_mention
- 2026-01-01 · lobbied for by FAEGRE DRINKER BIDDLE & REATH LLP $60,000 · lda_filing
- 2026-01-01 · lobbied on To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. (hr 1843) · lobbying_bill_mention
- 2026-01-01 · lobbied on Skinny Labels, Big Savings Act (s 43) · lobbying_bill_mention
Lobbying disclosures — as CLIENT (1)
Filings where this org hired a lobbying firm. Income + expenses come from the LDA disclosure.
| Posted | Filing | Year | Period | Registrant (lobbying firm) | Income | Expenses |
|---|---|---|---|---|---|---|
| 2026-04-16 | 1st Quarter - Report | 2026 | first_quarter | 12631 | $60,000 | — |
Aliases (1)
| source | id | name at source | jurisdiction | confidence | linked by | linked at |
|---|---|---|---|---|---|---|
| lda_client | 61034 | TEVA PHARMACEUTICALS USA, INC. | US | gold | backfill_0029 |
Outbound edges (5)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | lobbies_on_bill | HR 1843 — To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug | — | HR 1843 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1095 — Stop STALLING Act | — | S 1095 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1096 — Preserve Access to Affordable Generics and Biosimilars Act | — | S 1096 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1097 — Interagency Patent Coordination and Improvement Act of 2025 | — | S 1097 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 43 — Skinny Labels, Big Savings Act | — | S 43 | lobbying_bill_mention |
Inbound edges (3)
| date | from | type | amount | source |
|---|---|---|---|---|
| — | Elliot Vice | lobbied_for | — | lda_lobbyist_client |
| — | Megan Sussman Herber | lobbied_for | — | lda_lobbyist_client |
| 2026-01-01 | FAEGRE DRINKER BIDDLE & REATH LLP | lobbies_for | $60,000 | lda_filing |